Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
JOYY ADR | YY | Oct 31, 2024 | 34.05 | +0.68 |
JP Morgan Chase | JPM | Oct 31, 2024 | 221.92 | -1.11 |
JP Morgan Chase & Co EE Pref | JPM-C | Oct 31, 2024 | 25.71 | +0.55 |
JP Morgan Chase & Co GG Pref | JPM-J | Oct 31, 2024 | 22.94 | +0.61 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Oct 31, 2024 | 25.45 | +0.91 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Oct 31, 2024 | 54.58 | -1.85 |
Jumia Technologies ADR | JMIA | Oct 31, 2024 | 4.60 | -3.77 |
Junee Limited - Ordinary Shares | JUNE | Oct 31, 2024 | 4.85 | -6.55 |
Junior Gold Miners ETF Market Vectors | GDXJ | Oct 31, 2024 | 51.58 | -2.72 |
Juniper Networks | JNPR | Oct 31, 2024 | 38.90 | -0.13 |
JVSPAC Acquisition | JVSA | Oct 31, 2024 | 10.37 | 0.00 |
JVSPAC Acquisition | JVSAU | Oct 31, 2024 | 10.75 | 0.00 |
JX Luxventure | JXJT | Oct 31, 2024 | 1.33 | +0.98 |
Kadant | KAI | Oct 31, 2024 | 333.06 | -0.79 |
Kairos Pharma | KAPA | Oct 31, 2024 | 1.31 | 0.00 |
Kairous Acquisition | KACL | Oct 31, 2024 | 12.08 | -0.08 |
Kaiser Aluminium | KALU | Oct 31, 2024 | 74.26 | -3.24 |
Kaival Brands Innovations Group | KAVL | Oct 31, 2024 | 1.00 | +1.52 |
Kaixin Auto | KXIN | Oct 31, 2024 | 4.08 | -1.69 |
Kala Bio | KALA | Oct 31, 2024 | 7.04 | +2.77 |
Kaltura | KLTR | Oct 31, 2024 | 1.27 | -3.05 |
KalVista Pharmaceuticals | KALV | Oct 31, 2024 | 10.27 | -8.30 |
Kamada | KMDA | Oct 31, 2024 | 5.74 | +2.50 |
Kandi Technologies Group | KNDI | Oct 31, 2024 | 1.29 | -3.36 |
Kanzhun ADR | BZ | Oct 31, 2024 | 14.55 | -2.68 |
Karat Packaging | KRT | Oct 31, 2024 | 26.70 | -0.74 |
Karooooo | KARO | Oct 31, 2024 | 40.00 | -2.44 |
Kartoon Studios | TOON | Oct 31, 2024 | 0.74 | -3.78 |
Karyopharm Therapeutics | KPTI | Oct 31, 2024 | 0.99 | +17.81 |
Katapult | KPLT | Oct 31, 2024 | 8.42 | -1.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.